North America Insulin Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers North America Insulin Pump Manufacturers and It is Segmented by Components (insulin Pump Device, Infusion Set, And Reservoir) and Geography (United States, Canada, And the Rest of North America). The Market Provides the Value (in USD) and Volume (in Units) for the Above Segments.

North America Insulin Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

North America Insulin Infusion Pumps Market Size

View Global Report
North America Insulin Infusion Pumps Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 2.97 Billion
Market Size (2030) USD 4.01 Billion
CAGR (2025 - 2030) 6.18 %

Major Players

North America Insulin Infusion Pumps Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of North America Insulin Infusion Pumps Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

North America Insulin Infusion Pumps Market Analysis

The North America Insulin Infusion Pumps Market size is estimated at USD 2.97 billion in 2025, and is expected to reach USD 4.01 billion by 2030, at a CAGR of 6.18% during the forecast period (2025-2030).

In North America, till April 2022, the United States is having the highest COVID cases with 82 million, the country also registered the highest death rate. According to the Diabetes Voice article published in May 2020, close to 40,000 deaths of people who are having diabetes. In the North American region diabetes patients are more concerned about stocking up the monitoring and managing devices due to this the market increased during these years.

The North American region had witnessed an astounding increase in the prevalence of diabetes, in recent years. In developed countries, such as the United States and Canada, the rate of diabetes is at an all-time high, mainly due to lifestyle changes. Diabetes is associated with many health complications. Comparing the population with and without diabetes, those with diabetes have a 300% increased risk of being hospitalized and thus incur more healthcare expenses compared to non-diabetic people. 

Patients with Type 2 diabetes require many corrections throughout the day to maintain nominal blood glucose levels, such as administering additional insulin or ingesting additional carbohydrates. Furthermore, patients attempting to control their blood glucose levels tightly to prevent the long-term complications associated with fluctuations in blood glucose levels are at greater risk for overcorrection and the resultant hypoglycemia. Achieving nominal results can be very difficult without multiple daily injections of insulin or insulin pump therapy.

An insulin pump (also known as continuous subcutaneous insulin therapy) is a medical device used to administer insulin to treat diabetes. Insulin pumps make it possible to deliver continuous infusion amounts of insulin at regular intervals. It is predicted to result in long-term cost savings relative to multiple daily injections. 

The traditional pump includes the pump (including controls, a processing module, and batteries), a disposable reservoir for insulin (inside the pump), and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula. The device configuration may vary depending on the design. However, the application of infusion pumps is increasing significantly across the world.

North America Insulin Infusion Pumps Industry Overview

The new technologies in insulin infusion pump devices increased the market for Insulin Pump devices. Animas had to exit the insulin pump market owing to the rising competition. Medtronic is the market leader and is expected to maintain its position during the forecast period.

North America Insulin Infusion Pumps Market Leaders

  1. Medtronic

  2. Insulet

  3. Ypsomed

  4. Tandem

  5. Ascensia

  6. *Disclaimer: Major Players sorted in no particular order
North America Insulin Infusion Pumps Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

North America Insulin Infusion Pumps Market News

  • August 2023: The US Food and Drug Administration (FDA) has granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free "patch" pump for people with diabetes who use insulin.
  • February 2022: The US Food and Drug Administration (FDA) approved Tandem Diabetes Care's t: slim X2 insulin pump to bolus using the t: connect mobile app. The updated mobile application is intended to allow users of the t: slim X2 insulin pump to easily program and cancel bolus insulin requests through their smartphone.

North America Insulin Infusion Pumps Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Component
    • 5.1.1 Insulin Pump
    • 5.1.2 Infusion Set
    • 5.1.3 Reservoir
  • 5.2 Geography
    • 5.2.1 United States
    • 5.2.2 Canada
    • 5.2.3 Rest of North America

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Medtronic
    • 7.1.2 Insulet
    • 7.1.3 Roche
    • 7.1.4 Animas
    • 7.1.5 Tandem
    • 7.1.6 Ypsomed
    • 7.1.7 Cellnovo
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Roche
    • 7.2.2 Animas
    • 7.2.3 Medtronic
    • 7.2.4 Other Company Share Analyses

8. MARKET OPPORTUNITES AND FUTURE TRENDS

**Subject to Availability
*We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents. **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Insulin Infusion Pumps Industry Segmentation

An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump is composed of a pump reservoir similar to an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end, through which insulin passes. The North American insulin infusion pump market is segmented by component and geography. The report offers the value (in USD) and volume (in units) for the above segments. We will provide a segment-wise breakdown (value and volume) for all the countries covered under the table of contents.

Component Insulin Pump
Infusion Set
Reservoir
Geography United States
Canada
Rest of North America
Need A Different Region or Segment?
Customize Now

North America Insulin Infusion Pumps Market Research FAQs

How big is the North America Insulin Infusion Pumps Market?

The North America Insulin Infusion Pumps Market size is expected to reach USD 2.97 billion in 2025 and grow at a CAGR of 6.18% to reach USD 4.01 billion by 2030.

What is the current North America Insulin Infusion Pumps Market size?

In 2025, the North America Insulin Infusion Pumps Market size is expected to reach USD 2.97 billion.

Who are the key players in North America Insulin Infusion Pumps Market?

Medtronic, Insulet, Ypsomed, Tandem and Ascensia are the major companies operating in the North America Insulin Infusion Pumps Market.

What years does this North America Insulin Infusion Pumps Market cover, and what was the market size in 2024?

In 2024, the North America Insulin Infusion Pumps Market size was estimated at USD 2.79 billion. The report covers the North America Insulin Infusion Pumps Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Insulin Infusion Pumps Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

North America Insulin Infusion Pumps Industry Report

Statistics for the 2025 North America Insulin Infusion Pumps market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Insulin Infusion Pumps analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.